(A) = The EU reference labs identified the reference standard for fluroxypyr conjugates as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 1 July 2016, or, if that reference standard is not commercially available by that date, the unavailability of it.